Transcat, Inc. (NASDAQ:TRNS) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Transcat, Inc. (NASDAQ:TRNS) have earned an average recommendation of “Moderate Buy” from the four research firms that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $142.67.

A number of brokerages recently weighed in on TRNS. HC Wainwright raised their price target on shares of Transcat from $124.00 to $156.00 and gave the company a “buy” rating in a report on Wednesday, May 22nd. Northland Securities lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 22nd. Northland Capmk downgraded Transcat from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 22nd. Finally, Oppenheimer upped their target price on Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research report on Wednesday, May 22nd.

Transcat Trading Down 1.1 %

Shares of TRNS opened at $121.59 on Monday. The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of 76.47 and a beta of 0.68. The company has a quick ratio of 2.62, a current ratio of 3.14 and a debt-to-equity ratio of 0.01. The stock’s 50-day moving average price is $119.12 and its 200 day moving average price is $110.07. Transcat has a 12-month low of $81.26 and a 12-month high of $147.00.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, May 20th. The scientific and technical instruments company reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.25. The company had revenue of $70.91 million during the quarter, compared to analysts’ expectations of $68.76 million. Transcat had a return on equity of 9.50% and a net margin of 5.26%. As a group, research analysts predict that Transcat will post 2.01 earnings per share for the current year.

Insider Transactions at Transcat

In other news, Director Charles P. Hadeed sold 1,358 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total transaction of $176,540.00. Following the sale, the director now directly owns 21,320 shares in the company, valued at $2,771,600. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Charles P. Hadeed sold 1,358 shares of the stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $130.00, for a total transaction of $176,540.00. Following the completion of the sale, the director now directly owns 21,320 shares in the company, valued at $2,771,600. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider James M. Jenkins sold 5,514 shares of the company’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $137.18, for a total value of $756,410.52. Following the sale, the insider now owns 1,619 shares in the company, valued at approximately $222,094.42. The disclosure for this sale can be found here. In the last quarter, insiders sold 24,588 shares of company stock valued at $3,233,507. Corporate insiders own 4.20% of the company’s stock.

Institutional Investors Weigh In On Transcat

A number of hedge funds have recently added to or reduced their stakes in TRNS. Charles Schwab Investment Management Inc. boosted its holdings in Transcat by 14.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 68,339 shares of the scientific and technical instruments company’s stock worth $7,472,000 after acquiring an additional 8,857 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Transcat by 13.3% in the 3rd quarter. Vanguard Group Inc. now owns 425,378 shares of the scientific and technical instruments company’s stock worth $41,674,000 after purchasing an additional 49,828 shares during the last quarter. Wasatch Advisors LP increased its position in shares of Transcat by 13.3% during the fourth quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company’s stock valued at $76,651,000 after acquiring an additional 82,458 shares in the last quarter. Monashee Investment Management LLC bought a new stake in Transcat in the 3rd quarter worth about $588,000. Finally, Quadrature Capital Ltd bought a new stake in Transcat in the 3rd quarter worth approximately $2,847,000. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.